Literature DB >> 16454944

Reprogramming of human somatic cells by embryonic stem cell cytoplast.

Nick Strelchenko1, Valeri Kukharenko, Artem Shkumatov, Oleg Verlinsky, Anver Kuliev, Yury Verlinsky.   

Abstract

Somatic cell nuclear transfer (SCNT) provides the basis for the development of patient-specific stem cell lines. Recent progress in SCNT suggested the presence of reprogramming factors in human embryonic stem (hES) cells, although no method is currently available for replacement of nuclei of hES cells by somatic cell nuclei. An original technique has been developed, involving the fusion of different types of somatic cells with hES cells, which allowed a complete replacement of the nuclei of hES cells by nuclei of somatic cells. The resulting 'cybrids' were demonstrated to have the genotype of the donor somatic cells and 'stemness' of the recipient hES cells. However, the colonies isolated from the resulting fusion contained a mixture of these cybrid cells with the cells with the recipient nuclei, as well as hybrid cells containing both donor and recipient nuclei, so future purification will be necessary before the technique can be considered for future practical application.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16454944     DOI: 10.1016/s1472-6483(10)60988-1

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  13 in total

Review 1.  Altered nuclear transfer: a way forward for embryonic stem cell research.

Authors:  William B Hurlbut
Journal:  Stem Cell Rev       Date:  2005-12       Impact factor: 5.739

Review 2.  Alternative sources of pluripotent stem cells: altered nuclear transfer.

Authors:  M L Condic
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 3.  Reprogramming somatic gene activity by fusion with pluripotent cells.

Authors:  Jeong Tae Do; Dong Wook Han; Hans R Schöler
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 4.  Cell fusion for reprogramming pluripotency: toward elimination of the pluripotent genome.

Authors:  Danièle Pralong; Alan O Trounson; Paul J Verma
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

5.  From embryonic stem cells to iPS - an ethical perspective.

Authors:  J Suaudeau
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 6.  Parthenogenesis as an approach to pluripotency: advantages and limitations involved.

Authors:  Tiziana A L Brevini; Georgia Pennarossa; Stefania Antonini; Fulvio Gandolfi
Journal:  Stem Cell Rev       Date:  2008-06-12       Impact factor: 5.739

Review 7.  Pluripotency and nuclear reprogramming.

Authors:  Shinya Yamanaka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

Review 8.  Interspecies somatic cell nuclear transfer and preliminary data for horse-cow/mouse iSCNT.

Authors:  R Tayfur Tecirlioglu; Jitong Guo; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 9.  Cytoplasmic cell fusion: Stembrid technology for reprogramming pluripotentiality.

Authors:  Yury Verlinsky; Nick Strelchenko; Artem Shkumatov; Valeri Kukharenko; Oleg Verlinsky; Anver Kuliev
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

10.  Human therapeutic cloning (NTSC): applying research from mammalian reproductive cloning.

Authors:  Andrew J French; Samuel H Wood; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.